Accessibility Menu
 
Nova Eye Medical logo

Nova Eye Medical

(ASX) EYE

Current Price$0.12
Market Cap$34.18M
Since IPO (1992)-49%
5 Year-65%
1 Year+9%
1 Month-20%

Nova Eye Medical Financials at a Glance

Market Cap

$34.18M

Revenue (TTM)

$59.16M

Net Income (TTM)

$15.59M

EPS (TTM)

$-0.02

P/E Ratio

-4.82

Dividend

$0.00

Beta (Volatility)

-0.06 (Low)

Price

$0.12

Volume

62,043

Open

$0.13

Previous Close

$0.12

Daily Range

$0.12 - $0.13

52-Week Range

$0.10 - $0.20

EYE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nova Eye Medical

Industry

Healthcare Equipment and Supplies

CEO

Thomas Spurling

Headquarters

Kent Town, SA 5067, AU

EYE Financials

Key Financial Metrics (TTM)

Gross Margin

67%

Operating Margin

-16%

Net Income Margin

-21%

Return on Equity

-42%

Return on Capital

-29%

Return on Assets

-30%

Earnings Yield

-20.75%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$34.18M

Shares Outstanding

284.84M

Volume

62.04K

Short Interest

0.00%

Avg. Volume

498.98K

Financials (TTM)

Gross Profit

$20.07M

Operating Income

$11.25M

EBITDA

$8.98M

Operating Cash Flow

$6.15M

Capital Expenditure

$426.00K

Free Cash Flow

$6.58M

Cash & ST Invst.

$5.05M

Total Debt

$3.02M

Nova Eye Medical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$16.71M

+64.8%

Gross Profit

$11.72M

+786.3%

Gross Margin

70.11%

N/A

Market Cap

$34.18M

N/A

Market Cap/Employee

$113.56K

N/A

Employees

301

N/A

Net Income

$3.37M

+40.2%

EBITDA

$2.36M

+43.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$2.32M

-265.9%

Accounts Receivable

$4.10M

+85.8%

Inventory

$3.50M

-15.3%

Long Term Debt

$4.29M

+668.2%

Short Term Debt

$646.00K

-50.8%

Return on Assets

-29.70%

N/A

Return on Invested Capital

-29.00%

N/A

Free Cash Flow

$2.41M

+46.1%

Operating Cash Flow

$2.28M

+44.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BDX.AXBCAL Diagnostics Limited
$0.09+2.22%
HMD.AXHeraMED Limited
$0.04-4.35%
MAP.AXMicroba Life Sciences Limited
$0.07+2.90%
LGP.AXLittle Green Pharma Ltd
$0.10+3.19%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.32-0.01%
NOKNokia
$9.38-0.02%
TQQQProShares Trust - ProShares UltraPro Qqq
$48.98+0.00%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.45-0.05%

Questions About EYE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.